Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey Mark Drazen, M.D.


This page shows the publications co-authored by Jeffrey Drazen and Lester Kobzik.
Connection Strength

  1. Human neutrophil elastase-mediated goblet cell metaplasia is attenuated in TACE-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2013 May 15; 304(10):L701-7.
    View in: PubMed
    Score: 0.133
  2. Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med. 1999 May 17; 189(10):1621-30.
    View in: PubMed
    Score: 0.051
  3. Contribution of type I NOS to expired gas NO and bronchial responsiveness in mice. Am J Physiol. 1997 10; 273(4):L883-8.
    View in: PubMed
    Score: 0.046
  4. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med. 1996 May; 153(5):1510-4.
    View in: PubMed
    Score: 0.041
  5. Substance P-induced histamine release in tracheally perfused guinea pig lungs. J Appl Physiol (1985). 1995 Apr; 78(4):1234-41.
    View in: PubMed
    Score: 0.038
  6. Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs. J Clin Invest. 1994 Jun; 93(6):2667-74.
    View in: PubMed
    Score: 0.036
  7. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 1993 Oct; 9(4):371-7.
    View in: PubMed
    Score: 0.035
  8. Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness. J Appl Physiol (1985). 2004 Jul; 97(1):249-59.
    View in: PubMed
    Score: 0.018
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.